Cardiol Therapeutics (OTCMKTS:CRTPF) Trading 4.5% Higher

Cardiol Therapeutics Inc. (OTCMKTS:CRTPFGet Free Report)’s share price traded up 4.5% on Tuesday . The company traded as high as $1.84 and last traded at $1.84. 162,971 shares were traded during trading, an increase of 143% from the average session volume of 67,097 shares. The stock had previously closed at $1.76.

Cardiol Therapeutics Trading Up 4.5 %

The business has a 50 day simple moving average of $1.67 and a two-hundred day simple moving average of $1.19.

About Cardiol Therapeutics

(Get Free Report)

Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.

See Also

Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with's FREE daily email newsletter.